Erudio Healtherudio.com
Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Stichting Hemato-Oncologie voor Volwassenen Nederland yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Stichting Hemato-Oncologie voor Volwassenen Nederland: EMN02, EVOLVE-1 and HOVON 150 AML. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Stichting Hemato-Oncologie voor Volwassenen Nederland). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| EMN02 NCT01208766 · Stichting Hemato-Oncologie voor Volwassenen Nederland DeepView → | newly diagnosed multiple myeloma | Phase 3 | Deep | View | |||
| EVOLVE-1 NCT07075016 · Stichting Hemato-Oncologie voor Volwassenen Nederland FocusedView → | IDH1-mutated AML or MDS/AML ineligible for intensive chemotherapy | Phase 3 | Focused | View | |||
| HOVON 150 AML NCT03839771 · Stichting Hemato-Oncologie voor Volwassenen Nederland FocusedView → | IDH1/IDH2-mutated acute myeloid leukemia or myelodysplastic syndrome EB2 | Phase 3 | Focused | View | |||